TY - JOUR
T1 - OPTN/SRTR 2019 Annual Data Report
T2 - Pancreas
AU - Kandaswamy, R.
AU - Stock, P. G.
AU - Miller, J.
AU - Skeans, M. A.
AU - White, J.
AU - Wainright, J.
AU - Kyaw, N. T.T.
AU - Niederhaus, S.
AU - Israni, A. K.
AU - Snyder, J. J.
N1 - Publisher Copyright:
© 2021 The American Society of Transplantation and the American Society of Transplant Surgeons.
PY - 2021/2
Y1 - 2021/2
N2 - The overall number of pancreas transplants decreased slightly, from 1027 in 2018 to 1015, in 2019, up from a nadir of 947 in 2015. However, the number of simultaneous pancreas-kidney transplants (SPKs) increased in 2019, with a corresponding drop in pancreas-after-kidney transplants (PAKs) and pancreas transplants alone (PTAs). New waitlist registrations increased to 1772 in 2019, from 1606 in 2018. This was predominately driven by SPK listings, and those with type 2 diabetes. Waiting time for SPK decreased by 2 months, to a median of 12 months in 2019, but PTA recipient mean waiting time remained substantially higher, at 24 months, in 2018. Both short- and long-term outcomes, including patient survival, kidney graft survival, and acute rejection-free graft survival, have shown consistent improvement over the last decade. Pancreas graft survival data with the uniform definition of allograft failure is being collected by the Organ Procurement and Transplant Network (OPTN) and will be included in a future report.
AB - The overall number of pancreas transplants decreased slightly, from 1027 in 2018 to 1015, in 2019, up from a nadir of 947 in 2015. However, the number of simultaneous pancreas-kidney transplants (SPKs) increased in 2019, with a corresponding drop in pancreas-after-kidney transplants (PAKs) and pancreas transplants alone (PTAs). New waitlist registrations increased to 1772 in 2019, from 1606 in 2018. This was predominately driven by SPK listings, and those with type 2 diabetes. Waiting time for SPK decreased by 2 months, to a median of 12 months in 2019, but PTA recipient mean waiting time remained substantially higher, at 24 months, in 2018. Both short- and long-term outcomes, including patient survival, kidney graft survival, and acute rejection-free graft survival, have shown consistent improvement over the last decade. Pancreas graft survival data with the uniform definition of allograft failure is being collected by the Organ Procurement and Transplant Network (OPTN) and will be included in a future report.
KW - pancreas after kidney transplant
KW - Pancreas transplant
KW - pancreas transplant alone
KW - simultaneous kidney pancreas transplant
UR - http://www.scopus.com/inward/record.url?scp=85101059148&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101059148&partnerID=8YFLogxK
U2 - 10.1111/ajt.16496
DO - 10.1111/ajt.16496
M3 - Article
C2 - 33595197
AN - SCOPUS:85101059148
SN - 1600-6135
VL - 21
SP - 138
EP - 207
JO - American Journal of Transplantation
JF - American Journal of Transplantation
IS - S2
ER -